購(gòu)物車(chē)
幫助
021-54845833/15800441009
技術(shù)規(guī)格
|
Background: |
Hydroxysteroid (17-beta) dehydrogenase 13, also designated Short-chain dehydrogenase/reductase 9 (SCDR9), which regulate the availability of steroids within various tissues throughout the body. HSD17B13 is a 300 amino acid secreted protein that is highly expressed in liver and is also detected in ovary, bone marrow, kidney, brain, lung, skeletal muscle, bladder and testis. The gene encoding HSD17B13 maps to chromosome 4, which houses nearly 6% of the human genome and has the largest gene deserts (regions of the genome with no protein encoding genes) of all of the human chromosomes. Defects in some of the genes located on chromosome 4 are associated with Huntington's disease, Ellis-van Creveld syndrome, methylmalonic acidemia and polycystic kidney disease. |
|
Applications: |
ELISA, IHC |
|
Name of antibody: |
HSD17B13 |
|
Immunogen: |
Fusion protein of human HSD17B13 |
|
Full name: |
hydroxysteroid (17-beta) dehydrogenase 13 |
|
Synonyms： |
SCDR9; NIIL497; SDR16C3; HMFN0376 |
|
SwissProt: |
Q7Z5P4 |
|
ELISA Recommended dilution: |
2000-5000 |
|
IHC positive control: |
Human ovarian cancer and human colon cancer |
|
IHC Recommend dilution: |
50-200 |
